Stephan Christgau, PhD
Stephan Christgau has broad executive experience from private as well as public biotech companies with responsibilities for R&D, operations, clinical development and corporate strategy. Stephan currently serves as a founding Partner of Eir Ventures Partners AB, a Swedish life sciences venture capital fund. Stephan was a founding member of the corporate life science venture capital group Novo Seeds and for more than 12 years has worked in life science venture capital as an active company creator and early investor. His investments have mainly focused on the Nordic area, where Stephan has led the creation and funding of more than 20 companies. Dr. Christgau holds an MSc in Biochemical Engineering from the Technical University of Denmark and a Ph.D. in protein chemistry and immunology from the University of California San Francisco.